InvestorsChronicle of the WeekTime to close the chapter on this publishing houseIt’s behind the brand that brought joy to millions, but its focus on series could leave it on rockier foundationsSave17 July 2025
InvestorsChronicle of the WeekA foundry operator forging a stronger futureMargins should recover as investments peak and the demand cycle turnsSave10 July 2025
InvestorsChronicle of the WeekThis dividend-paying bargain carmaker is ready to re-rateShares are down following dwindling sales and manufacturing issues, but a healthy balance sheet means it won’t need much to bounce backSave10 July 2025
InvestorsChronicle of the WeekA niche manufacturer profiting from smart diversification Electric vehicle-driven growth stood out in the company’s recent strong resultsSave3 July 2025
InvestorsChronicle of the WeekThis copper miner is ready to break outA new mine on the way plus added tonnes from an existing site provide growth and a reliable income streamSave3 July 2025
InvestorsChronicle of the WeekThis trust takes a shrewd approach to emerging marketsPolitical uncertainty will continue, but this fund’s novel stockpicking strategy could help to navigate itSave26 June 2025
InvestorsChronicle of the WeekA cosmetics player starting to look more attractiveThe shares have sold off on the threat of tariffs, but the US is only a small part of the company’s business Save26 June 2025
InvestorsChronicle of the WeekThis bargain AI stock is ready to prove its doubters wrongThe chip designer faces strategic challenges, but has a strong balance sheet and impressive cash flow Save19 June 2025
InvestorsChronicle of the WeekA smart shift means this beleaguered outsourcer is now a buyShares have further to run as this group’s shift to defence and the US plays outSave19 June 2025
InvestorsChronicle of the WeekThis pharma giant has been oversold Fears about the erosion of future revenues as patents expire have weighed on Merck’s valuationSave12 June 2025